The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-MET co-expressing metastatic pancreatic adenocarcinoma.
 
Olumide B. Gbolahan
No Relationships to Disclose
 
Amikar Sehdev
Consulting or Advisory Role - Gerson Lehrman Group
 
Safi Shahda
Consulting or Advisory Role - AstraZeneca; Bayer; Merrimack
Research Funding - Myriad Genetics
 
Susan Perkins
No Relationships to Disclose
 
Murray Korc
No Relationships to Disclose
 
Patrick J. Loehrer
Research Funding - Lilly Foundation (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)
 
Bert H. O'Neil
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; Halozyme
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Bayer; Merck KGaA